☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
AbCellera
AbCellera Enters into a Collaboration Agreement with Prelude Therapeutics to Develop Antibody Drug Conjugated to Treat Cancer
November 2, 2023
AbCellera Collaborated with Rallybio to Develop and Commercialize Novel Antibody-Based Therapies for the Treatment of Rare Disease...
December 1, 2022
AbCellera Collaborated with Atlas Venture to Discover Therapeutic Antibodies Against Three Drug Targets
August 3, 2022
PharmaShots Weekly Snapshots (October 11 - 15, 2021)
October 15, 2021
PharmaShots Weekly Snapshots (September 20 - 24, 2021)
September 24, 2021
PharmaShots Weekly Snapshots (August 02 - 06, 2021)
August 6, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.